NO20022253D0 - Middel til behandling av hepatitt C - Google Patents

Middel til behandling av hepatitt C

Info

Publication number
NO20022253D0
NO20022253D0 NO20022253A NO20022253A NO20022253D0 NO 20022253 D0 NO20022253 D0 NO 20022253D0 NO 20022253 A NO20022253 A NO 20022253A NO 20022253 A NO20022253 A NO 20022253A NO 20022253 D0 NO20022253 D0 NO 20022253D0
Authority
NO
Norway
Prior art keywords
hepatitis
agent
treatment
Prior art date
Application number
NO20022253A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022253L (no
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of NO20022253L publication Critical patent/NO20022253L/no
Publication of NO20022253D0 publication Critical patent/NO20022253D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20022253A 2000-03-22 2002-05-10 Middel til behandling av hepatitt C NO20022253D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
PCT/AT2001/000076 WO2001070203A2 (de) 2000-03-22 2001-03-20 Mittel zur behandlung von hepatitis c, enthaltend ukrain

Publications (2)

Publication Number Publication Date
NO20022253L NO20022253L (no) 2002-05-10
NO20022253D0 true NO20022253D0 (no) 2002-05-10

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022253A NO20022253D0 (no) 2000-03-22 2002-05-10 Middel til behandling av hepatitt C

Country Status (17)

Country Link
JP (1) JP2003527414A (zh)
KR (1) KR20020087045A (zh)
CN (1) CN1416347A (zh)
AT (1) AT408719B (zh)
AU (1) AU2001239000A1 (zh)
BG (1) BG107088A (zh)
BR (1) BR0107211A (zh)
CA (1) CA2389173A1 (zh)
EA (1) EA200200584A1 (zh)
HR (1) HRP20020367A2 (zh)
IL (1) IL149314A0 (zh)
IS (1) IS6360A (zh)
MA (1) MA25509A1 (zh)
MX (1) MXPA02004993A (zh)
NO (1) NO20022253D0 (zh)
PL (1) PL365000A1 (zh)
WO (1) WO2001070203A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2008039179A1 (en) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
PL365000A1 (en) 2004-12-27
MXPA02004993A (es) 2003-10-14
IS6360A (is) 2002-04-24
WO2001070203A2 (de) 2001-09-27
KR20020087045A (ko) 2002-11-21
ATA4812000A (de) 2001-07-15
NO20022253L (no) 2002-05-10
JP2003527414A (ja) 2003-09-16
WO2001070203A3 (de) 2002-09-06
HRP20020367A2 (en) 2004-02-29
IL149314A0 (en) 2002-11-10
AU2001239000A1 (en) 2001-10-03
MA25509A1 (fr) 2002-07-01
BG107088A (en) 2003-05-30
AT408719B (de) 2002-02-25
EA200200584A1 (ru) 2003-06-26
BR0107211A (pt) 2004-01-06
CN1416347A (zh) 2003-05-07
CA2389173A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20022087L (no) Fremgangsmåte for behandling av diabetes
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
IS6917A (is) Epóþílon afleiður til meðhöndlunar erfiðra æxla
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
DE60136477D1 (de) Retinoide zur behandlung von emphysem
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
DK1197485T3 (da) Cyclobutendionderivater til behandling af artherosclerose
DK1200114T3 (da) PPAR delta inhibitorer til behandling af kardiovaskulære sygdomme
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20022253L (no) Middel til behandling av hepatitt C
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme